Christopher Sorli
Chief Tech/Sci/R&D Officer presso ACERUS PHARMACEUTICALS CORPORATION
Profilo
Christopher Sorli is currently the Chief Medical Officer at Acerus Pharmaceuticals Corp.
Prior to this, he worked at Sanofi SA from 2016 to 2020, where he held the position of VP-Medical Affairs & Head-Cardio Metabolic Disease from 2019 to 2020.
Posizioni attive di Christopher Sorli
| Società | Posizione | Inizio |
|---|---|---|
| ACERUS PHARMACEUTICALS CORPORATION | Chief Tech/Sci/R&D Officer | 17/07/2020 |
Precedenti posizioni note di Christopher Sorli
| Società | Posizione | Fine |
|---|---|---|
| Sanofi SA | Corporate Officer/Principal | 01/07/2020 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
| Sanofi SA | Health Technology |
Acerus Pharmaceuticals Corp.
 Acerus Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Acerus Pharmaceuticals Corp. is a pharmaceutical company. The firm is focused on the commercialization and development of prescription products that improve patient experience, with a focus in the field of men’s health. It focuses on therapeutics for urology, andrology, and endocrinology. Its products include Estrace and Natesto. The company was founded by Bruce D. Brydon, Rolf K. Reininghaus and Mark L. Thompson on September 9, 2008 and is headquartered in Mississauga, Canada. | Health Technology |
- Borsa valori
- Insiders
- Christopher Sorli
